Objective: To investigate the use of the retronasal triangle (RNT) for identification of orofacial cleft (OC) in the first trimester and the clinical application of three-dimensional (3D) ultrasound techniques for confirming the diagnosis of OC. Methods: A total of 5,054 women with singleton pregnancies underwent first-trimester screening for Down syndrome at 11-13+6 weeks. The RNT was scanned in each fetus, and 3D volumetric images of cases with abnormal or indeterminate RNT were obtained. Results: Satisfactory images were obtained from all cases. Seven cases (1.4‰) of abnormal RNT were diagnosed as OC in the first trimester, which were confirmed at a 16 weeks scan or at a postmortem examination. One case that was considered a normal RNT was diagnosed with OC at 22+2 weeks and after term delivery. Six cases of indeterminate RNT were diagnosed as normal by 3D ultrasound. Identification of OC by visualization of the RNT in the first trimester had a sensitivity of 87.5% and a specificity of 99.9%. Conclusion: The RNT is an important sonographic landmark that has a high sensitivity and specificity for the detection of OC in the first trimester. 3D ultrasound is an important tool that aids in confirming diagnosis of OC in the first and second trimesters.

Keywords:
First-trimester screening, Retronasal triangle, Orofacial cleft, Three-dimensional ultrasound
1.
Vanderas AP: Incidence of cleft lip, cleft palate, and cleft lip and palate among races: a review. Cleft Palate J 1987;24:216-225.
2.
IPDTOC Working Group: Prevalence at birth of cleft lip with or without cleft palate: data from the International Perinatal Database of Typical Oral Clefts (IPDTOC). Cleft Palate Craniofac J 2011;48:66-81.
3.
Brizot ML, Snijders RJ, Bersinger NA, Kuhn P, Nicolaides KH: Maternal serum pregnancy-associated plasma protein A and fetal nuchal translucency thickness for the prediction of fetal trisomies in early pregnancy. Obstet Gynecol 1994;84:918-922.
4.
Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH: UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group. Lancet 1998;352:343-346.
5.
Nicolaides KH: Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities. Am J Obstet Gynecol 2004;191:45-67.
6.
Economides DL, Braithwaite JM: First trimester ultrasonographic diagnosis of fetal structural abnormalities in a low risk population. Br J Obstet Gynaecol 1998;105:53-57.
8.
Li W-J: Clinical significance of fetal chromosomal abnormalities, serology and ultrasound morphology prenatal screening. J Pract Obstet Gynecol 2006;22:134-136.
9.
Li W-J, Yan R-L, Zhang Y-L, Zhou Q: Clinical significance of ultrasound first-trimester screening of multiple indicators for fetal chromosomal abnormalities. Chin J Perinat Med 2013;2:82-85.
10.
Sepulveda W, Wong AE, Martinez-Ten P, Perez-Pedregosa J: Retronasal triangle: a sonographic landmark for the screening of cleft palate in the first trimester. Ultrasound Obstet Gynecol 2010;35:7-13.
11.
Martinez-Ten P, Adiego B, Illescas T, Bermejo C, Wong AE, Sepulveda W: First-trimester diagnosis of cleft lip and palate using three-dimensional ultrasound. Ultrasound Obstet Gynecol 2012;40:40-46.
12.
Lidral AC, Romitti PA, Basart AM, et al: Association of MSX1 and TGFB3 with nonsyndromic clefting in humans. Am J Hum Genet 1998;63:557-568.
13.
Calzolari E, Pierini A, Astolfi G, Bianchi F, Neville AJ, Rivieri F; EUROCAT Working Group: Associated anomalies in multi-malformed infants with cleft lip and palate: an epidemiologic study of nearly 6 million births in 23 EUROCAT registries. Am J Med Genet Part A 2007;143A:528-537.
14.
Wu Y-Q, Zeng M, Xu C-L, Liang J, Wang Y-P, Miao L, Xiao K: Analysis on incidence of neural tube defects and cleft lip and palate deformities in China, 1988-1991. Journal of West China University of Medical Sciences 1995;26:215-219.
15.
Stoll C, Alembik Y, Dott B, Roth MP: Epidemiological and genetic study in 207 cases of oral cleft in Alsace, north-eastern France. J Med Genet 1991;28:325-329.
16.
Chmait R, Pretorius D, Moore T, Hull A, James G, Nelson T, Jones M: Prenatal detection of associated anomalies in fetuses diagnosed with cleft lip with or without cleft palate in utero. Ultrasound Obstet Gynecol 2006;27:173-176.
17.
Gillhan JC, Anand S, Bullen PJ: Antenatal detection of cleft lip with or without cleft palate: incidence of associated chromosomal and structural anomalies. Ultrasound Obstet Gynecol 2009;34:410-415.
18.
Berge SJ, Plath H, Van de Vondel PT, Appel T, Niederhagen B, Von Lindern JJ, Reich RH, Hansmann M: Fetal cleft lip and palate: sonographic diagnosis, chromosomal abnormalities, associated anomalies and postnatal outcome in 70 fetuses. Ultrasound Obstet Gynecol 2001;18:422-431.
19.
Ghi T, Perolo A, Banzi C, Contratti G, Valeri B, Savelli L, Morselli GP, Bovicelli L, Pilu G: Two-dimensional ultrasound is accurate in the diagnosis of fetal craniofacial malformation. Ultrasound Obstet Gynecol 2002;19:543-551.
20.
Chen ML, Chang CH, Yu CH, Cheng YC, Chang FM: Prenatal diagnosis of cleft palate by three-dimensional ultrasound. Ultrasound Med Biol 2001;27:1017-1023.
21.
Cash C, Set P, Coleman N: The accuracy of antenatal ultrasound in the detection of facial clefts in a low-risk screening population. Ultrasound Obstet Gynecol 2001;18:432-436.
22.
Clementi M, Tenconi R, Bianchi F, Stoll C: Evaluation of prenatal diagnosis of cleft lip with or without cleft palate and cleft palate by ultrasound: experience from 20 European registries. EUROSCAN study group. Prenat Diagn 2000;20:870-875.
23.
Shaikh D, Mercer NS, Sohan K, Kyle P, Soothill P: Prenatal diagnosis of cleft lip and palate. Br J Plast Surg 2001;54:288-289.
24.
Becker R, Wegner RD: Detailed screening for fetal anomalies and cardiac defects at the 11-13-week scan. Ultrasound Obstet Gynecol 2006;27:613-618.
25.
Syngelaki A, Chelemen T, Dagklis T, Allan L, Nicolaides KH: Challenges in the diagnosis of fetal non-chromosomal abnormalities at 11-13 weeks. Prenat Diagn 2011;31:90-102.
26.
Gullino E, Serra M, Ansaldi C, Massobrio M, Pagliano M: Bilateral cleft lip and palate diagnosed sonographically at 11 weeks of pregnancy. J Clin Ultrasound 2006;34:398-401.
27.
Borenstein M, Persico N, Dagklis T, Faros E, Nicolaides KH: Frontomaxillary facial angle in fetuses with trisomy 13 at 11 + 0 to 13 + 6 weeks. Ultrasound Obstet Gynecol 2007;30:819-823.
28.
Martinez-Ten P, Adiego B, Perez-Pedregosa J, Illescas T, Wong AE, Sepulveda W: First-trimester assessment of the nasal bones using the retronasal triangle view: a 3-dimensional sonographic study. J Ultrasound Med 2010;29:1555-1561.
29.
Ghi T, Arcangeli T, Radico D, Cavallotti D, Contro E, Pelusi G: Three-dimensional sonographic imaging of fetal bilateral cleft lip and palate in the first trimester. Ultrasound Obstet Gynecol 2009;34:119-120.
30.
Tonni G, Grisolia G, Sepulveda W, et al: Early prenatal diagnosis of orofacial clefts: evaluation of the retronasal triangle using a new three-dimensional reslicing technique. Fetal Diagn Ther 2013;34:31-37.
31.
Sepulveda W, Wong AE, Vinals F, Andreeva E, Adzehova N, Martinez-Ten P: Absent mandibular gap in the retronasal triangle view: a clue to the diagnosis of micrognathia in the first trimester. Ultrasound Obstet Gynecol 2012;39:152-156.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.